#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16196	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2304	699.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1455	1455	C	1031	C,A	927,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16196	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2304	699.0	0	HET	.	.	.	C207T	.	207	207	C	478	478	C	895	C,T	643,166	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29706	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3539	836.6	0	.	n	.	0	T695C	SNP	695	695	T	999	999	C	911	C	827	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29706	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3539	836.6	0	.	n	.	0	A1638G	SNP	1638	1638	A	1942	1942	G	1016	G,A	924,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29706	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3539	836.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2275	2275	C	944	C,G	854,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29706	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3539	836.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2349	2349	A	942	A	863	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29706	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3539	836.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2901	2901	C	898	C	831	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	2146	folP	852	852	99.77	folP.l15.c4.ctg.1	1555	137.1	0	.	p	.	0	S68P	NONSYN	202	204	TCG	480	482	CCG	225;228;227	C;C;G	205;207;208	.	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	2146	folP	852	852	99.77	folP.l15.c4.ctg.1	1555	137.1	0	.	p	.	0	A204V	NONSYN	610	612	GCA	888	890	GTA	191;192;192	G;T;A	178;179;177	.	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	2146	folP	852	852	99.77	folP.l15.c4.ctg.1	1555	137.1	1	SNP	p	R228S	1	.	.	682	684	AGC	960	962	AGC	209;208;210	A;G;C	193;194;193	folP.WHO_Z_01426c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6552	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3364	193.9	1	SNP	p	S91F	1	.	.	271	273	TTC	537	539	TTC	207;207;212	T;T;C	194;192;194	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6552	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3364	193.9	1	SNP	p	D95G	1	.	.	283	285	GGC	549	551	GGC	217;213;212	G;G;C	201;193;193	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6552	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3364	193.9	1	SNP	p	G95N	0	.	.	283	285	GGC	549	551	GGC	217;213;212	G;G;C	201;193;193	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1676	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1548	108.0	1	SNP	p	G45D	0	.	.	133	135	GGC	475	477	GGC	218;220;220	G;G;C	192;193;194	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	838	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1024	81.2	0	.	n	.	0	A197.	DEL	197	197	A	531	531	A	190	A	165	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6206	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3010	205.4	1	SNP	p	D86N	0	.	.	256	258	GAC	614	616	GAC	243;243;241	G;A;C,T	216;215;215,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6206	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3010	205.4	1	SNP	p	R87W	0	.	.	259	261	CGT	617	619	CGT	237;238;236	C;G;T	215;216;213	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6206	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3010	205.4	1	SNP	p	R87I	0	.	.	259	261	CGT	617	619	CGT	237;238;236	C;G;T	215;216;213	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6206	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3010	205.4	1	SNP	p	S87R	1	.	.	259	261	CGT	617	619	CGT	237;238;236	C;G;T	215;216;213	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6206	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3010	205.4	1	SNP	p	S88P	0	.	.	262	264	TCC	620	622	TCC	236;234;234	T;C;C	212;212;211	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4574	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2599	174.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1569	1571	GGC	222;220;218	G;G;C	205;201;198	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4336	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2280	188.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1209	1211	GCC	235;234;233	G;C;C	208;202;202	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4336	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2280	188.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1212	1214	ATG	232;231;232	A;T;G	206;205;204	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4336	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2280	188.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1224	1226	ACC	227;225;227	A;C;C	206;200;204	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4336	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2280	188.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1224	1226	ACC	227;225;227	A;C;C	206;200;204	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4336	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2280	188.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1725	1727	ACC	213;213;211	A;C;C	190;196;197	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4336	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2280	188.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1779	1781	GCG	206;202;206	G;C;G	187;184;183	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4336	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2280	188.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1779	1781	GCG	206;202;206	G;C;G	187;184;183	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4336	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2280	188.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1902	1904	GGT	192;193;193	G;G;T	167;168;165	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4336	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2280	188.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1911	1913	AGC	181;181;177	A;G;C	152;154;152	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4336	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2280	188.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1929	1931	CCG	137;140;141	C,G;C,G;GCCC,GGCCCCC,GCCCCC	98,9;102,1;89,1,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6358	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3075	206.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1655	1657	CCG	242;240;238	C;C;G	217;221;215	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2602	porA	1146	1146	99.91	porA.l6.c17.ctg.1	1845	140.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	602	602	C	177	C	158	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3090	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1691	181.7	1	SNP	p	G120K	1	.	.	358	360	AAG	635	637	AAG	264;264;264	A;A;G	234;240;235	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3090	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1691	181.7	1	SNP	p	A121N	1	.	.	361	363	AAC	638	640	AAC	263;260;256	A;A;C	239;236;234	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3090	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1691	181.7	1	SNP	p	N121D	0	.	.	361	363	AAC	638	640	AAC	263;260;256	A;A;C	239;236;234	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11562	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	5006	230.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1212	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1086	110.7	1	SNP	p	V57M	1	.	.	169	171	ATG	482	484	ATG	225;224;227	A,G;T;G,A	206,1;205;209,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
